A Study of BNC105P Combined With Ibrutinib

Clinical trial NCT03454165 · COMPLETED

Trial details

NCT number: NCT03454165
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2018-03-09
Primary completion: 2021-01-14
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.